Kelly Handley

3.6k total citations · 2 hit papers
36 papers, 2.0k citations indexed

About

Kelly Handley is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Kelly Handley has authored 36 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Surgery and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Kelly Handley's work include Colorectal Cancer Treatments and Studies (13 papers), Colorectal Cancer Surgical Treatments (7 papers) and Genetic factors in colorectal cancer (6 papers). Kelly Handley is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Colorectal Cancer Surgical Treatments (7 papers) and Genetic factors in colorectal cancer (6 papers). Kelly Handley collaborates with scholars based in United Kingdom, Netherlands and United States. Kelly Handley's co-authors include Richard Gray, Philip Quirke, Laura Magill, Michel Seymour, David Kerr, Claire Beaumont, Katie Southward, Susan D. Richman, Gordon Hutchins and Philip Chambers and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Annals of Surgery.

In The Last Decade

Kelly Handley

32 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Value of Mismatch Repair, KRAS , and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

2011 505 citations Gordon Hutchins, Katie Southward et al. Journal of Clinical Oncology profile →
Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial

2023 181 citations Dion Morton, Michel Seymour et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Kelly Handley

Since Specialization

Citations

This map shows the geographic impact of Kelly Handley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Handley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Handley more than expected).

Fields of papers citing papers by Kelly Handley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Handley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Handley. The network helps show where Kelly Handley may publish in the future.

Co-authorship network of co-authors of Kelly Handley

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Handley. A scholar is included among the top collaborators of Kelly Handley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Handley. Kelly Handley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CT staging performance in an international trial of neoadjuvant chemotherapy for locally advanced colon cancer 2025 ·British Journal of Radiology ·(unknown), Faye Elliott, Kelly Handley, Laura Magill, Philip Quirke, Michel Seymour, Nicholas P. West, Dion Morton, Jenny F. Seligmann, Damian Tolan	0
2	Clinical statistical analysis plan for the ACCURE trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicentre trial 2024 ·Trials ·(unknown), (unknown), Shri Pathmakanthan, Willem A. Bemelman, Geert D’Haens, Kelly Handley, Apostolos Fakis, Thomas Pinkney, Christianne J. Buskens, Marcel G. W. Dijkgraaf	1
3	552P Baseline imaging biomarkers to predict outcomes in locally advanced colon cancer (LACC): Data from the FOxTROT international randomised-controlled trial 2024 ·Annals of Oncology ·(unknown), Faye Elliott, Philip Quirke, (unknown), Michel Seymour, (unknown), Kelly Handley, (unknown), Damian Tolan, Jenny F. Seligmann	1
4	Multi-arm multi-stage (MAMS) randomised selection designs: impact of treatment selection rules on the operating characteristics 2024 ·BMC Medical Research Methodology ·Babak Choodari‐Oskooei, Alexandra Blenkinsop, Kelly Handley, Thomas Pinkney, Mahesh Parmar	2
5	Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial breakdown → 2023 ·Journal of Clinical Oncology ·Dion Morton, Michel Seymour, Laura Magill, Kelly Handley, James Glasbey, Bengt Glimelius, Andy Palmer, Jenny F. Seligmann, Søren Laurberg, Keigo Murakami, Nicholas P. West, Philip Quirke, Richard Gray, (unknown)	181
6	552O FOxTROT: Results of embedded phase II evaluating the addition of panitumumab (pan) to neo-adjuvant FOLFOX for patients (pts) with KRAS-wt colon cancer (CC) with extended biomarker panel 2023 ·Annals of Oncology ·Jenny F. Seligmann, Dion Morton, Michel Seymour, Faye Elliott, Kelly Handley, Bengt Glimelius, Christopher J.M. Williams, Gemma Hemmings, (unknown), Richard Gray, Philip Quirke, Laura Magill, Andrew D. Beggs, Nicholas P. West	3
7	Prognostic and Predictive Value of Tumor Budding in Colorectal Cancer 2021 ·Clinical Colorectal Cancer ·Bojana Mitrovic, Kelly Handley, Naziheh Assarzadegan, (unknown), (unknown), Andrea Grin, Gordon Hutchins, Laura Magill, Philip Quirke, Robert H. Riddell, Richard Gray, Richard Kirsch	14
8	Anal fistula plug versus surgeon’s preference for surgery for trans-sphincteric anal fistula: the FIAT RCT 2019 ·Health Technology Assessment ·David Jayne, J H Scholefield, Damian Tolan, Richard Gray, Richard Edlin, Claire Hulme, Andrew Sutton, Kelly Handley, Catherine A Hewitt, Manjinder Kaur, Laura Magill	24
9	Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-study 2019 ·BMC Nephrology ·Darren Green, (unknown), Kelly Handley, Natalie Ives, Keith Wheatley, Constantina Chrysochou, Janet Hegarty, Julian Wright, Jon Moss, Rajan K. Patel, (unknown), John Webster, Peter A. Rowe, Sue Carr, Jenny Cross, Jamie M. O’Driscoll, (unknown), Patrick B. Mark, Philip A. Kalra	3
10	Intravenous remifentanil patient-controlled analgesia versus intramuscular pethidine for pain relief in labour (RESPITE): an open-label, multicentre, randomised controlled trial 2018 ·The Lancet ·Matthew Wilson, Christine MacArthur, Catherine A Hewitt, Kelly Handley, Fang Gao, Leanne Beeson, Jane Daniels	45
11	Intratumoral stromal morphometry predicts disease recurrence but not response to 5‐fluorouracil—results from the QUASAR trial of colorectal cancer 2017 ·Histopathology ·(unknown), Darren Treanor, Alexander Wright, Kelly Handley, Laura Magill, Emma Tinkler‐Hundal, Katie Southward, Michel Seymour, David Kerr, Richard Gray, Philip Quirke	22
12	The RESPITE trial: remifentanil intravenously administered patient-controlled analgesia (PCA) versus pethidine intramuscular injection for pain relief in labour: study protocol for a randomised controlled trial 2016 ·Trials ·(unknown), Matthew Wilson, Christine MacArthur, Fang Gao Smith, (unknown), Kelly Handley, Jane Daniels	5
13	HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials 2015 ·The Journal of Pathology ·Susan D. Richman, Katie Southward, Philip Chambers, (unknown), Jennifer H. Barrett, Gemma Hemmings, Morag Taylor, Henry M. Wood, Gordon Hutchins, Joseph Foster, Assa Oumie, Karen G. Spink, Sarah Brown, Marc Jones, David Kerr, Kelly Handley, Richard Gray, Michel Seymour, Philip Quirke	183
14	Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer 2013 ·European Journal of Cancer ·Daniel Rea, Richard Gray, S. Bowden, Kelly Handley, Helena Earl, C. J. Poole, T Bates, J A Dewar, (unknown), (unknown)	17
15	Dexamethasone reduces emesis after major gastrointestinal surgery (DREAMS) 2013 ·Trials ·Emma Hamilton, Reena Ravikumar, David Bartlett, (unknown), (unknown), (unknown), Sandeep Bahia, (unknown), (unknown), Kelly Handley, Laura Magill, Dion Morton	11
16	Value of Mismatch Repair, KRAS , and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer breakdown → 2011 ·Journal of Clinical Oncology ·Gordon Hutchins, Katie Southward, Kelly Handley, Laura Magill, Claire Beaumont, Jens Stahlschmidt, Susan D. Richman, Philip Chambers, Michel Seymour, David Kerr, Richard Gray, Philip Quirke	505
17	Accuracy of radiological staging in identifying high‐risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience 2011 ·Colorectal Disease ·S. Dighe, I. Swift, Laura Magill, Kelly Handley, Richard Gray, Philip Quirke, Dion Morton, Michel Seymour, Bryan F. Warren, Gina Brown	95
18	Meta‐analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease 2011 ·Movement Disorders ·Rebecca Stowe, Natalie Ives, Carl E Clarke, Kelly Handley, Alexandra Furmston, Katherine Deane, J.J. van Hilten, Keith Wheatley, Richard Gray	72
19	FOxTROT: Randomized phase II study of neoadjuvant chemotherapy (CT) with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer: Planned interim report. 2011 ·Journal of Clinical Oncology ·(unknown), Laura Magill, Kelly Handley, Gina Brown, D. Ferry, (unknown), Philip Quirke, Michel Seymour, (unknown), R Gray, (unknown)	0
20	Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications 2010 ·Cochrane Database of Systematic Reviews ·Rebecca Stowe, Natalie Ives, Carl E Clarke, Katherine Deane, (unknown), Keith Wheatley, Richard Gray, Kelly Handley, (unknown)	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact